| Title |
GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release
|
|---|---|
| Published in |
Trends in Endocrinology & Metabolism, October 2005
|
| DOI | 10.1016/j.tem.2005.08.005 |
| Pubmed ID | |
| Authors | |
| Abstract |
Heterotrimeric G proteins and seven-transmembrane-spanning (7TM) receptors are implicated in rapid estrogen signaling. The orphan 7TM receptor GPR30 is linked to estrogen-mediated activation of adenylyl cyclase, release of epidermal growth factor (EGF)-related ligands, and specific estrogen binding. GPR30 acts independently of estrogen receptors, ERalpha and ERbeta, and probably functions as a heptahelical ER. 7TM receptors elicit signals that stimulate second messengers, and convey intracellular signals via EGF receptors. Identification of GPR30 as a Gs-coupled 7TM receptor that triggers release of heparin-binding EGF establishes its role in cell signaling cascades initiated by estrogens, and explains their capacity to activate second messengers and promote EGF-like effects. Thus, estrogen can signal by the same mechanism as various other hormones, through a specific 7TM receptor. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 1% |
| United States | 1 | <1% |
| Mexico | 1 | <1% |
| Greece | 1 | <1% |
| United Kingdom | 1 | <1% |
| Switzerland | 1 | <1% |
| Brazil | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 146 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 38 | 25% |
| Researcher | 27 | 17% |
| Student > Master | 19 | 12% |
| Student > Bachelor | 15 | 10% |
| Professor | 10 | 6% |
| Other | 27 | 17% |
| Unknown | 19 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 59 | 38% |
| Biochemistry, Genetics and Molecular Biology | 21 | 14% |
| Medicine and Dentistry | 15 | 10% |
| Neuroscience | 13 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Other | 9 | 6% |
| Unknown | 31 | 20% |